Results 221 to 230 of about 673,953 (357)

Total Synthesis and Complete Stereochemical Assignment of Amphirionin‐5, a Potent Natural Osteoblasts Proliferator

ChemistryEurope, EarlyView.
The convergent total synthesis of a candidate diastereomer of amphirionin‐5 was accomplished in 22 steps via the coupling of the C1‐C16 enone segment and the C17‐C28 aldehyde segment using Stetter reaction. The overall stereochemistry of amphirionin‐5 was fully assigned, based on the comparison of spectroscopic and chiroptical data between the ...
Yusuke Ogura, Kenji Nemoto, Tadafumi Fujita, Yuta Inori, Daisuke Abe, Hironori Okamura, Hirosato Takikawa, Shigefumi Kuwahara   +7 more
wiley   +1 more source

An osteoporosis course as a separate component of problem-based learning. [PDF]

PLoS One
Hoffmanová I, Džupa V, Waldauf P, Grill R, Báča V.   +4 more
europepmc   +1 more source

Prevalence of Osteoporosis and Its Associated Factors among Older Men with Type 2 Diabetes [PDF]

, 2013
Hailing Chen, Lili Deng, Jufen Li
openalex   +1 more source

Analysis of the transcriptome in the TgRANKL mouse model of osteoporosis reveals mRNAs, miRNAs, and lncRNAs as potent regulators of osteoporosis

, 2022
Elisavet Ioannidou, Vagelis Rinotas, Eleni Douni   +2 more
openalex   +1 more source

The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Polypharmacy is increasingly recognized as a relevant issue in diabetes care, but its prevalence and clinical relevance in individuals with type 1 diabetes remain underexplored. This study aimed to determine the prevalence of polypharmacy and to identify associated clinical and psychological factors. Participants were recruited from a tertiary diabetes
Namam Ali, Stephan van Erp, Cornelis Kramers, Cornelis J. Tack, Bastiaan E. de Galan   +4 more
wiley   +1 more source

Polygenic Risk Score as a Predictor of Bone Fracture or Osteoporosis in Prostate Cancer Patients Receiving Androgen Deprivation Therapy. [PDF]

Cancer Med
Liu YQ, Chang LW, Yang HW, Li JR, Chen YM, Hung SC, Chen IC.   +6 more
europepmc   +1 more source

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

New England Journal of Medicine, 2017
K. Saag, J. Petersen, M. Brandi, A. Karaplis, M. Lorentzon, T. Thomas, J. Maddox, M. Fan, P. Meisner, A. Grauer   +9 more
semanticscholar   +1 more source

Cardiovascular Risk of Romosozumab vs. Teriparatide: A Cohort Study Using Japan’s National Claims Database

Clinical Pharmacology &Therapeutics, EarlyView.
Disproportionality analyses suggested a cardiovascular risk signal for romosozumab, while statistically significant associations were not found in the real‐world database studies. Therefore, a larger comparative study was necessary to examine this signal.
Hotaka Maruyama, Eiko Iwasa, Shinya Watanabe, Tomoaki Hasegawa, Kazuhiro Kajiyama, Taihei Tanaka   +5 more
wiley   +1 more source

Assessing the burden of osteoporosis and clinical fragility fractures in the French general population: insights from linked healthcare claims and health interview survey data used for surveillance. [PDF]

Arch Osteoporos
Coste J, Mandereau-Bruno L, Constantinou P, Makovski TT, Carcaillon-Bentata L, Guillemin F.   +5 more
europepmc   +1 more source

Noonan Syndrome and Osteoporosis: A Comprehensive Case Study and Literature Review

Mohamed Reyad, Mohamed R Murad, Ahmed Sobhy, Amr Hassan, Omar Nassar, Ahmed Hassan   +5 more
openalex   +1 more source